Thank you very much, Mr. Chair.
I will do my speech in English to avoid having to flip back and forth between the channels.
I appreciate the invitation to appear before the HESA committee. I will let you know that I have many departmental officials joining me today, including Dr. Stephen Lucas, deputy minister; Iain Stewart, president of the Public Health Agency of Canada; Dr. Theresa Tam, chief public health officer; Major-General Dany Fortin, vice-president, vaccine rollout task force, logistics and operations; Dr. Siddika Mithani, president of the Canadian Food Inspection Agency; and Catherine MacLeod, acting president of the Canadian Institutes of Health Research.
When I appeared before the committee last month, I provided an overview of Canada’s COVID-19 vaccination strategy. Today I would like to begin with a brief update on COVID-19 vaccinations and the situation in Canada right now.
So far we've delivered more than 3.8 million doses of COVID-19 vaccines to provinces and territories. More than two-thirds of these—a total of 2.6 million doses—have already been administered. We expect these numbers to rise quickly as deliveries from vaccine manufacturers continue to ramp up this month and in the months to follow. The recent authorizations of the AstraZeneca and Janssen vaccines by Health Canada give us two more tools in the fight against the pandemic.
Following the authorization of the AstraZeneca vaccine, the Minister of Public Services and Procurement announced that Canada has secured two million doses through an agreement with Verity Pharmaceuticals Inc., Canada, and the Serum Institute of India. This is in addition to the 20 million doses already secured through an earlier agreement with AstraZeneca.
The Janssen vaccine is administered in a single dose and can be stored and transported at regular refrigerated temperatures. Canada has an agreement with Johnson and Johnson for 10 million doses of this vaccine between now and September.
Although we've seen a decline in COVID-19 activity from mid-January through mid-February, daily case counts have since only levelled off, and COVID-19 variants could threaten the progress that we has been made if we relax public health measures too soon. That's why we all need to keep following public health measures that we know help identify and stop the spread of COVID-19. This includes testing, screening, contact tracing, and of course isolation. We also need to keep doing our part to protect each other. That means continuing to wear masks and limiting our interactions with other people.
Canada also has strong restrictions for travellers arriving in the country. In addition to being tested for COVID-19 before they arrive, travellers must now take a test on the day they arrive in Canada, and another on day 10 of their quarantine. All positive tests are evaluated to determine whether there are variants of concern. These strengthened requirements help protect the most vulnerable Canadians, and I want to thank the many Canadian travellers who are doing their part to protect their neighbours by following these new rules.
From the very first day, this pandemic has required us all to adapt and change our behaviours to protect public health. Canadians as individuals have had to do it, and so too have governments. As the pandemic has evolved, the federal response has evolved as well, and our budgetary needs reflect this.
I will now provide you with a financial overview for 2020-21 as set out in supplementary estimates (C). Through this exercise, I'm seeking $684.5 million on behalf of the health portfolio, which includes Health Canada, the Public Health Agency of Canada, the Canadian Food Inspection Agency and the Canadian Institutes of Health Research. This increase over the 2020-21 main estimates will complement work that is already under way in a number of important areas.
Beginning with Health Canada, I'm seeking an additional $603.1 million. This will increase the department’s statutory spending by $553.6 million and its voted spending authorities by $49.5 million. This funding will be used to address pressures associated with Canada’s COVID-19 response, as well as our obligations under the Economic Statement Implementation Act, 2020. This includes investments in long-term care, mental health and substance use in the context of COVID-19, as well as supporting innovative approaches to COVID-19 testing.
For the Public Health Agency of Canada, I'm requesting a total increase of $66.5 million. This reflects an increase of $5.634 billion in voted authorities, which is offset by a decrease in statutory spending of $5.567 billion.
The increase in voted authorities will go towards innovative research and the procurement of testing technologies related to the pandemic, surge capacity and support for mental health and substance-use initiatives.
For the Canadian Food Inspection Agency, or CFIA, I am seeking $13 million. This will increase the agency's statutory spending by $1.8 million and its voted spending authorities by $11.2 million. The majority of this funding will go towards improving existing domestic and import safety control systems through increased surveillance and inspection, supporting Canadian exports through the inspection and certification of goods, and the ongoing digitization of the agency's internal and public-facing business.
Another $1.5 million will support the Canadian food safety information network, which will improve confidence in the food safety system by connecting authorities and laboratories across jurisdictions.
Finally, for the Canadian Institutes of Health Research, I'm seeking $2 million. This will decrease its statutory spending by $126.7 million and increase its voted spending authorities by $128.7 million. These research investments will contribute to our overall understanding of COVID-19 and will continue to inform Canada's public health approach.
Mr. Chair, it has been a long road, but with vaccination under way across the country, we are closer than we have been in a long time to a more hopeful future. The Government of Canada is working steadily towards that future with actions that protect Canadians and safeguard the progress we've made.
Health Canada and the agencies of the health portfolio are proud to lead these efforts. Our resourcing plans reflect our commitment to ensuring the health and safety of Canadians during the COVID-19 pandemic and beyond. My colleagues and I will be happy to take your questions.
Thank you.